These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

265 related items for PubMed ID: 2860942

  • 1. Which component of sulphasalazine is active in rheumatoid arthritis?
    Pullar T, Hunter JA, Capell HA.
    Br Med J (Clin Res Ed); 1985 May 25; 290(6481):1535-8. PubMed ID: 2860942
    [Abstract] [Full Text] [Related]

  • 2. 5-Aminosalicylic acid or sulphapyridine. Which is the active moiety of sulphasalazine in rheumatoid arthritis?
    Taggart AJ, Neumann VC, Hill J, Astbury C, Le Gallez P, Dixon JS.
    Drugs; 1986 May 25; 32 Suppl 1():27-34. PubMed ID: 2877851
    [Abstract] [Full Text] [Related]

  • 3. A study to determine the active moiety of sulphasalazine in rheumatoid arthritis.
    Neumann VC, Taggart AJ, Le Gallez P, Astbury C, Hill J, Bird HA.
    J Rheumatol; 1986 Apr 25; 13(2):285-7. PubMed ID: 2873245
    [Abstract] [Full Text] [Related]

  • 4. [Effect of 5-aminosalicylic acid as a constituent of sulfasalazine in the treatment of chronic polyarthritis].
    Wörth WD, Müller W.
    Z Rheumatol; 1986 Apr 25; 45(2):79-82. PubMed ID: 2873695
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Active therapeutic moiety of sulphasalazine.
    van Hees PA, van Tongeren JH, Bakker JH, van Lier HJ.
    Lancet; 1978 Feb 04; 1(8058):277. PubMed ID: 74700
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Therapeutic efficacy of sulfasalazine and its metabolites in patients with ulcerative colitis and Crohn's disease.
    Klotz U, Maier K, Fischer C, Heinkel K.
    N Engl J Med; 1980 Dec 25; 303(26):1499-502. PubMed ID: 6107853
    [Abstract] [Full Text] [Related]

  • 10. Clinical experience of the tolerance of mesalazine and olsalazine in patients intolerant of sulphasalazine.
    Rao SS, Cann PA, Holdsworth CD.
    Scand J Gastroenterol; 1987 Apr 25; 22(3):332-6. PubMed ID: 2884724
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The effect of sulphasalazine on neutrophil superoxide generation in rheumatoid arthritis.
    Bradley SM, le Gallez P, Throughton PR, Gooi HC, Astbury C, Bird HA.
    Br J Rheumatol; 1997 May 25; 36(5):530-4. PubMed ID: 9189053
    [Abstract] [Full Text] [Related]

  • 15. Plasma and synovial fluid concentrations of sulphasalazine and two of its metabolites in rheumatoid arthritis.
    Farr M, Brodrick A, Bacon PA.
    Rheumatol Int; 1985 May 25; 5(6):247-51. PubMed ID: 2906452
    [Abstract] [Full Text] [Related]

  • 16. Comparison of the single dose pharmacokinetics of sulphasalazine in rheumatoid arthritis and inflammatory bowel disease.
    Astbury C, Taggart AJ, Juby L, Zebouni L, Bird HA.
    Ann Rheum Dis; 1990 Aug 25; 49(8):587-90. PubMed ID: 1975737
    [Abstract] [Full Text] [Related]

  • 17. Clinical pharmacokinetics of sulphasalazine, its metabolites and other prodrugs of 5-aminosalicylic acid.
    Klotz U.
    Clin Pharmacokinet; 1985 Aug 25; 10(4):285-302. PubMed ID: 2864155
    [Abstract] [Full Text] [Related]

  • 18. Clinical tolerance to three 5-aminosalicylic acid releasing preparations in patients with inflammatory bowel disease intolerant or allergic to sulphasalazine.
    Giaffer MH, O'Brien CJ, Holdsworth CD.
    Aliment Pharmacol Ther; 1992 Feb 25; 6(1):51-9. PubMed ID: 1347468
    [Abstract] [Full Text] [Related]

  • 19. Sulphasalazine in rheumatoid arthritis: a double blind comparison of sulphasalazine with placebo and sodium aurothiomalate.
    Pullar T, Hunter JA, Capell HA.
    Br Med J (Clin Res Ed); 1983 Oct 15; 287(6399):1102-4. PubMed ID: 6138117
    [Abstract] [Full Text] [Related]

  • 20. Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial.
    Rachmilewitz D.
    BMJ; 1989 Jan 14; 298(6666):82-6. PubMed ID: 2563951
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.